MDAI MDAI
Company Profile ↓Company Overview
MDAI (MDAI) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 132.2%, reflecting efficient use of shareholder capital.
Recent Developments
- Dec 2025 Revenue of $19.65M (-33.6% YoY); net profit $-7.57M.
- Trailing 12 Months Year-on-year growth — revenue -33.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -8.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -8.16% |
| 1 Year: | -33.57% |
Stock Price Performance
| 1 Year: | -32.64% |
| 6 Months: | -6.32% |
| 3 Months: | -28.19% |
| 1 Month: | -6.32% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.62 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 132.2%.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -8.2% CAGR over 5 years.
- Trading 39.2% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 7.04M | 5.08M | 4.25M | 3.44M | 6.33M | 7.48M | 8.17M | 6.71M | 5.07M | 3.79M | 3.99M |
| Gross Profit | - | - | - | - | - | 3.23M | 2.18M | 1.79M | 1.47M | 2.94M | 3.31M | 3.67M | 3.17M | 2.29M | 1.62M | 2.03M |
| Operating Income | -157.82K | -287.04K | -1.19M | -465.12K | -248.72K | -251.00K | -2.90M | -2.99M | -4.17M | -2.14M | -2.44M | -886.00K | -896.00K | -2.12M | -3.34M | -1.97M |
| Net Income | 3.22M | -2.90M | 2.23M | -528.00K | -265.00K | -380.00K | -3.61M | -3.07M | -10.63M | -3.21M | -2.86M | -1.50M | 2.90M | -7.97M | -3.55M | -3.41M |
| Diluted EPS | - | - | - | - | - | -0.03 | -0.27 | -0.23 | -0.77 | -0.19 | -0.16 | -0.08 | 0.11 | -0.31 | -0.13 | -0.11 |
| R&D Expense | - | - | - | - | - | - | 4.00M | - | - | 4.30M | - | - | 3.60M | - | - | 2.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 25.37M | 18.06M | 29.58M | 19.65M |
| Gross Profit | - | 10.84M | 7.88M | 13.27M | 8.93M |
| Operating Income | -3.42M | -2.65M | -12.98M | -6.58M | -8.60M |
| Net Income | -2.15M | -2.91M | -20.85M | -15.16M | -7.57M |
| Diluted EPS | - | -0.22 | -1.48 | -0.85 | -0.29 |
| R&D Expense | - | 16.50M | 15.10M | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | 164.90K | 254.11M | 18.72M | 10.69M | 12.10M | 21.41M |
| Total Equity | 24.32K | 13.75M | 12.00M | -2.15M | -7.25M | -5.73M |
| Cash & Equivalents | - | 769.43K | 14.17M | 4.79M | 5.20M | 15.40M |
| Long Term Debt | - | - | - | - | - | 5.54M |
| Total Liabilities | 140.57K | 21.93M | 6.72M | 12.40M | 19.35M | 27.13M |
| Current Liabilities | 140.57K | 2.94M | 6.37M | 12.40M | 17.64M | 20.63M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -1.16M | -13.24M | -9.20M | -9.92M |
| Investing Cash Flow | -7.00K | 0 | - | - | - |
| Financing Cash Flow | - | -785.00K | 3.84M | 9.57M | 20.12M |
| Capital Expenditure | -7.00K | - | - | - | - |
| Free Cash Flow | - | -1.16M | -13.24M | -9.20M | -9.92M |
| Net Change in Cash | - | -1.95M | -9.40M | 376.00K | 10.20M |
| Share Buybacks | 0 | 250.52M | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 42.7% | 43.6% | 44.9% | 45.4% |
| Operating Margin % | - | -10.4% | -71.9% | -22.3% | -43.8% |
| Net Margin % | - | -11.5% | -115.5% | -51.2% | -38.5% |
| ROE % | -15.6% | -24.3% | 970.4% | 209.0% | 132.2% |
| ROCE % | -1.4% | -21.4% | 759.7% | 118.6% | -1,104.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MDAI
Analyst Estimates: Here's What Brokers Think Of Spectral AI, Inc. (NASDAQ:MDAI) After Its First-Quarter Report - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOV09lV2QxbW1nLV9VdDVwd21jcDVHS2JISEpCM0RCV1cwdVN4bVV3dU1aVW1pNEFLR1htWHhwM2x1Y25HdHgwTFE0dWRvT1ktNXhXbWJzLTd5S0dKS0FhZUhGd2diUURwWVMzSFUwdWhnVElWLWxLczRtb0lLR2lQVlFhalNJV0hLOFNuZ0…
Wound-Care AI Company Spectral AI Sets Aug. 11 Results Call - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNTUZKVHVwU2dBWXV0LWE1OUxWWUF4YW55VTVYUWFlTzdKMlVLMjJ2UHpKRnRCZUZSdEllckJTZ255STNDR3cyc0U0dDZjaDdNTWd1V3hnTlpzdWQtN2x5QVU4RHFxUGFsaTRUUEtyQVlhaFE4UlJncFg5N19nRTR6azRzSkwwVWRyWkZCZT…
SPECTRAL AI ($MDAI) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQTEFWb2JUWTA1OFg0M0U5c3lEV0w0ckU2dnJKYjgyTnViZ1RHczlVX2F3eC1NcDRUYl9lMDBHeERFOVpzTzY1MmwxTUg1VUx2Y1plUnZGeENQU1VtNm94OF9mOTRxU1JZTVQxbUI2UTlBT2tzQjZQTXBPMWFoRi1rYk02Y3hsX0w5Nkt6V2…
Spectral AI Inc (MDAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBIWUQzb19zR3R3a2FKUVR4d2JId3NvcktRUGRIbGxNSFR6NlFDWlZQOW5kYzNoNy1JdGFoWTJITmRRZndBVXVuLWJ2ZVdfM2VITVo0UTlqREtPX3pjem95bWN3cFIzQQ?oc=5" target="_blank">Spectral AI Inc (MDAI) Earnin…
MDAI Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE53Y3ZEQmJYcTJQZDhreXp5S25JUkU1cEhNb2dKQ2ZPaGttalltVGt2OVRiM2NxTHR0cFFwUVFnTkhlOXAxOXRmcjRHM1ktNjZmdTNybUdib3hQTThFbXc?oc=5" target="_blank">MDAI Should I Buy</a> <font c…
MDAI Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9rSU9odHZFTTRZTEtwZEhlZzFzZXNzdmdmaWZ4QlR3UFI0ZVYwVFkySVZidVJzNFVZYVUyMUs5WU1uMXl4c2ZNenNWem9XV2I0T1BweURWSGxTRVJlU2ZQN18yZC1fNllxZ1oyTFF6T05sc2hyd0ZPdXFn?oc=5" target="_blank">MDA…
MDAI — Frequently Asked Questions
What is the current share price of MDAI?
As of 2026-08-05 17:25 PDT, MDAI trades at $1.63 on NASDAQ/NYSE. Its 52-week range is $1.20 to $2.68.
What is the P/E ratio of MDAI?
MDAI trades at a trailing price-to-earnings (P/E) ratio of -5.62.
What is the return on equity (ROE) of MDAI?
MDAI has a return on equity (ROE) of 132.20%.
Is MDAI a good stock to buy?
This page provides a data-driven analysis of MDAI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.